Author: Piers Townley

There have been a number of headlines over the last two days about a ‘new treatment’ that may save thousands of lives for brain tumour patients

A new type of drug that targets a particular protein could become the first ever treatment designed for children with diffuse midline gliomas (formerly known as DIPG)

This weekend marks a year since Tessa Jowell died from a brain tumour

Research presented recently at a conference in Milan showed that a particular type of radiation therapy could help spare children’s memory and thinking when they undergo treatment for brain tumours

A research team from Germany has used artificial intelligence to improve the assessment of treatment response in brain tumours

NHS England are currently running a questionnaire to find out more about people’s experiences of Personal Health Budgets, which could feed into and shape the future of personalised healthcare

The Charity’s corporate partnerships officer Steve Salazar, has been pounding the training miles

A recent study highlights gaps in neuro-onoclogy services provided nationally

Recent research has shown that sex differences impact outcomes for people diagnosed with a glioblastoma. These differences go beyond hormone influences and were found to be intrinsic to tumour cells

We explore some of the barriers that will need to be overcome in order to implement the NHS Long Term Plan.

In this second part of our coverage we look at what’s missing form the NHS Long Term Plan

Today, the NHS Long Term Plan has been published setting out the future of NHS services. The plan has been eagerly awaited by healthcare professionals, charities and patients alike

Research, funded by us as part of the INSTINCT programme, has found differences between aggressive atypical teratoid rhabdoid tumours (ATRTs) and other brain tumours.

Our successful Ask the Researcher event will give you the chance to hear more about how we’re moving closer to a cure

The All Party Parliamentary Group on Children, Teenagers and Young Adults with Cancer (APPG CTYAC) is a cross-party group which is raising awareness and representing young people who have been personally affected by cancer

Our scientists in Heidelberg and London have discovered what drives the unpredictable growth of low grade brain tumours

On Wednesday we hosted a Parliamentary reception to celebrate the accomplishments and progress that has been made in this disease area since the launch of our strategy in 2015

Kelly Dawson’s appointment at Nottingham University Hospitals is part of our landmark strategy of improving the quality for all those diagnosed

Yesterday, we attended the Britain Against Cancer conference which celebrated 20 years of the All Party Parliamentary Group on Cancer (APPGC). Our Policy and Public Affairs Officer Helena Brown, reports.

SNO is an annual conference where those at the forefront of research to defeat brain tumours come together to share their work, discuss the progress that has been made and consider strategies for future development

We recently represented the charity at an international scientific conference called SNO in New Orleans

Hundreds more brain tumour patients are set to be offered access to experimental treatments over the next five years thanks to the Tessa Jowell BRAIN-MATRIX

Researchers have discovered a new drug could potentially halt the spread of glioblastoma cells

This month The Charity convened a series of meetings with a number of Assembly Members in Wales, lobbying them on some of the most important issues affecting brain tumour patients in Wales